Heart Failure Online 2022 On-demand
Published: 09 May 2022
20m 17sPart 2 | Session 1 Session 2.1 - Patient Case: HF Aetiology
59m 46sPart 2 | Session 2 Session 2.2 - Live MitraClip Case
1h 13m 43sPart 2 | Session 3 Session 2.3 - Practical Theory and Hot Topics
21m 30sPart 2 | Session 4 Session 2.4 - Patient Case Revisited: Advanced HF Care
1h 44sPart 2 | Session 5 Session 2.5 - Practical Theory and Hot Topics
1h 20m 4sPart 3 | Session 2 Session 3.2 - Practical Theory and Hot Topics
40mPart 3 | Session 3 Session 3.3 - Live CRT Case
46m 49sPart 3 | Session 4 Symposium - Making Gains in HFpEF: An Appraisal of Where We Are Now
20m 49sPart 1 | Session 1 Session 1:1 - Patient Case: The Complex Patient Andrew JS Coats, Shelley Zieroth, Carolyn Lam, Ewa Jankowska, Ileana L Piña
1h 3m 43sPart 1 | Session 2 Session 1.2 - Practical Theory and Hot Topics Andrew JS Coats, Shelley Zieroth, Javed Butler, Ewa Jankowska, Carolyn Lam, Ileana L Piña
23m 51sPart 1 | Session 3 Session 1.3 - Patient Case Revisited: Transitioning Care and Monitoring Technology Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
58m 23sPart 1 | Session 4 Session 1.4 - Practical Theory and Hot Topics Ileana L Piña, Philipp Lurz, Loreena Hill, Harriette Van Spall, Rajiv Sankaranarayanan
Heart Failure Online (HFO) is a new innovative virtual event, that brings together a leading international faculty to create a rich, interactive experience to best inform the global heart failure community of the latest developments and advances in clinical practice.
With patient management and outcomes at its core, Course Director Prof Andrew Coats (President of the Heart Failure Association and Professor of Cardiology, University of Warwick, UK) leads an interactive programme of discussion, opinion and case studies focusing on the patient journey.
Note, the live version of this session was CME accredited; this on-demand version is not.
Key Learning Objectives
Following the activities, participants will be able to:
- Select foundational and advanced management strategies in complex patients
- Discuss the validity of using ejection fraction to determine optimal treatment strategies
- Assess the likely impact of health technology on future practice
- Identify the underlying causes of heart failure
- Select appropriate interventional and device-based treatments for treating underlying causes of heart failure
- Assess the impact of the multidisciplinary team on heart failure outcomes
- Discuss the importance of using quality of life and patient self-assessed measures relative to hard clinical end points
- Heart Failure Specialists
- General Cardiologists
- General Practitioners (GPs)
- Nurses, Pharmacists, and other Allied Healthcare Professionals
More from this programme
Day One: Individualising Treatment
Day Two: Complex Phenotypes and Advanced Treatment
Day Three: Beyond Foundational Management
Andrew JS Coats
Professor of Cardiology and Scientific Director
Prof Coats is Editor-in-Chief of the Cardiac Failure Review journal. He has published over 20 patents, more than 750 full research papers and more than 120,000 career citations and has a personal H-index of 146. Andrew was elected to the Presidential Trio of the Heart Failure Association of the ESC in 2018 and will serve as its president from 2020-2022.
Prof Coats is the Immediate past-President of the Heart Failure Association and past-Professor of Cardiology at the University of Warwick, UK. He has also held posts as Head of Cardiology at Imperial College, London and Associate Medical Director and Director of Cardiology at the Royal Brompton and Harefield Hospitals, London. From 2012 to 2017 he was Director of the Monash-Warwick Alliance, and before that served as Deputy Vice-Chancellor and Dean of Medicine at the University of Sydney.
He is an…
Dr Biykem Bozkurt is the Immediate Past President of the Heart Failure Society of America.
Dr Bozkurt is a Professor of Medicine, an advanced heart failure and cardiac transplantation specialist, Medical Care Line Executive (Medicine Department Chair) at the DeBakey VA Medical Center; W.A. “Tex” and Deborah Moncrief, Jr., Chair; Mary and Gordon Cain Chair; Vice-Chair of Department of Medicine; Director of the Winters Center for Heart Failure and Associate Director of Cardiovascular Research Institute at Baylor College of Medicine.
Dr Mikhail Kosiborod is a cardiologist, the Vice President of Research at Saint Luke's Health System, and Professor of Medicine at the University of Missouri-Kansas City, US.
He is also Director of Cardiometabolic Research and Co-Director of the Saint Luke’s Michael & Marlys Haverty Cardiometabolic Center of Excellence at Saint Luke's Mid America Heart Institute. Dr Kosiborod is an internationally-recognised expert in the fields of diabetes and cardiovascular disease, cardiometabolic and cardiorenal syndromes.
Dr Kosiborod is involved in the leadership of numerous clinical trials and multi-center registries, and is currently the principal investigator of several investigator-initiated, multi-center trials in diabetes and cardiovascular disease.